Maalox Plus chewable tablets

Maalox is a globally recognized brand of antacid medications, widely used to treat heartburn, acid indigestion, and stomach upset. The brand was originally developed in the United States by William H. Rorer, Inc. around 1949. Its name is a portmanteau of its primary ingredients: Magnesium and Aluminum hydroxides.

Today, Maalox is part of the consumer healthcare portfolio of Sanofi, a leading global pharmaceutical company headquartered in France. While the brand has global reach, the specific 'Maalox Plus' version shown (indicated by the Italian text 'compresse masticabili') is manufactured and distributed within Italy. In 2024, Sanofi completed the spin-off of its consumer healthcare business into an independent listed entity named Opella, which now manages the Maalox brand globally under the Sanofi umbrella.